Search results
Results from the WOW.Com Content Network
Cyclobenzaprine, sold under several brand names including, historically, Flexeril, is a muscle relaxer used for muscle spasms from musculoskeletal conditions of sudden onset. [5] It is not useful in cerebral palsy. [5] It is taken by mouth. [5] Common side effects include headache, feeling tired, dizziness, and dry mouth. [5]
Where risks or harms is the reason for withdrawal, this will usually have been prompted by unexpected adverse effects that were not detected during Phase III clinical trials, i.e. they were only made apparent from postmarketing surveillance data collected from the wider community over longer periods of time.
(Note that while the above anabolic steroids remain available in at least one formulation, many of the above-listed brand names have been discontinued.) Ethylestrenol (Maxibolin) and stanozolol (Winstrol) were previously available but were discontinued.
The drugs have faced public backlash over their high price, fueling demand for cheaper alternatives. The list, which includes 15 drugs, up from 10 last year, is the first step in a negotiation ...
The sale of these drugs would be less of a problem if the price of the original drugs were not so high, Califf told reporters at a media roundtable. "I'm very worried about the internet ...
GLP-1 drugs do a lot more than just help you lose weight. They can help your heart, brain, and more, but beware what they might do to muscle and skin.
The clinical effectiveness of methocarbamol compared to other muscle relaxants is not well known. [12] One trial of methocarbamol versus cyclobenzaprine, a well-studied muscle relaxant, in those with localized muscle spasm found there were no significant differences in their effects on muscle spasm, limitation of motion, or limitation of daily activities.
Mazindol is used in short-term (i.e., a few weeks) treatment of obesity, in combination with a regimen of weight reduction based on caloric restriction, exercise, and behavior modification in people with a body mass index greater than 30, or in those with a body mass index greater than 27 in the presence of risk factors such as hypertension, diabetes, or hyperlipidemia.